Actively Recruiting
TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
Led by Ottawa Hospital Research Institute · Updated on 2024-04-30
108
Participants Needed
1
Research Sites
385 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will compare total shoulder arthroplasty (TSA) with an augmented glenoid component and reverse shoulder arthroplasty (RSA) procedures, in participants with advanced glenohumeral osteoarthritis aged 65 years and older, who also present with greater than 15 degrees of glenoid retroversion, in the context of a prospective, randomized controlled trial to determine the optimal treatment in this patient population.
CONDITIONS
Official Title
TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of idiopathic shoulder osteoarthritis
- Failed standard non-surgical treatment of shoulder osteoarthritis for at least 6 months including medications, physiotherapy, and activity modification
- Imaging and surgery findings confirming advanced cartilage loss in the shoulder joint
- Glenoid bone deficiency with more than 15 degrees and up to 26 degrees of glenoid retroversion
- Age 65 years or older
You will not qualify if you...
- Active joint or systemic infection
- Rotator cuff arthropathy
- Significant muscle paralysis
- Charcot's arthropathy
- Major medical illness with life expectancy less than 1 year or high operative risk
- Unable to understand the consent process
- Pregnancy
- Psychiatric illness preventing informed consent
- Unwilling to participate for the full study duration
- Glenoid retroversion that cannot be surgically corrected to within 10 degrees of neutral
- Previous surgery on the affected shoulder
- Rheumatoid arthritis in the affected shoulder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H8L6
Actively Recruiting
Research Team
K
Katie McIlquham
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here